文献速递前列腺癌

新型活检下载系统对前列腺癌检出率、监测与局灶治疗的影响——一项前瞻性研究

Implications of a Novel Biopsy Downloading System on Prostate Cancer Detection Rate, Surveillance and Focal Therapy - A Prospective Study.
PubMed 文献 · Urology · 2021-11-12

这项前瞻性研究收集了429例经直肠超声活检患者的6014条活检组织芯,比较SmartBx下载系统与标准下载法的组织芯长度、产出率和癌症检出率。SmartBx组组织芯长度(12.3mm vs 10mm)和产出率(77.5% vs 62.2%)均显著更高,PSA<10患者中癌症检出率也显著更高(10.1% vs 7.96%)。SmartBx芯内癌长度显著低于标准阳性全芯(4.45mm vs 10.9mm),假定癌灶为完美球体时芯内病变体积较全芯低11倍(46.1mm vs 679.9mm)。

要点

  • SmartBx组组织芯长度12.3mm vs 标准法10mm,产出率77.5% vs 62.2%,均显著更高。
  • PSA<10患者中SmartBx组癌症检出率10.1% vs 标准法7.96%,差异显著。
  • SmartBx芯内癌长度4.45mm vs 标准阳性全芯10.9mm,显著更低。

核心结论

  • SmartBx导致显著更高的组织芯长度、产出率和癌症检出率。
  • 芯内肿瘤病灶的精确 локализация允许显著减少肿瘤体积。

研究设计与样本

  • 前瞻性收集经直肠超声活检患者的组织芯,一半使用SmartBx,一半使用标准下载法。
  • 共收集429例患者的6014条组织芯,测量前约3200条组织芯经各病理步骤的长度及160条SmartBx芯的芯内癌长度。
  • 比较SmartBx与标准芯的组织芯长度、产出率(最终分析可用芯长/针上原始芯长)和癌症检出率,采用t检验或卡方检验分析。

主要发现

  • SmartBx组组织芯长度12.3mm vs 标准法10mm(P<.01),产出率77.5% vs 62.2%(P<.01),均显著更高。
  • PSA<10患者中SmartBx组癌症检出率10.1% vs 标准法7.96%(n=2080 vs n=2073,P<.016),显著更高。
  • 其他亚组中SmartBx芯癌症检出率数值更高但无统计学显著差异,并注意到临床显著前列腺癌检出率更高。
  • 160条SmartBx芯的芯内癌长度4.45mm vs 标准阳性全芯10.9mm(P<.001),显著更低。
  • 假定癌灶为完美球体,芯内病变体积46.1mm vs 全芯679.9mm(P<.0001),低11倍。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the SmartBx, a novel biopsy downloading system, allowing downloading of biopsy cores with maximal core preservation as prostate biopsy sampling lacks preservation of core configuration & orientation. METHODS: We prospectively collected cores from TRUS biopsy patients. Half were collected using the SmartBx & half using standard downloading. We measured length of the first ∼3200 cores through various pathology steps and within core cancer length in 160 SmartBx cores. We compared core length, yield (% of core available for final analysis/ original core on needle) and cancer detection rate between SmartBx and standard cores. T-test or chi-square were used for analysis. RESULTS: 6014 cores were collected from 429 patients. Core length (12.3mm vs. 10mm; P<.01) and core yield (77.5% vs. 62.2%; P<.01) were significantly higher using the SmartBx compared to standard method, respectively. Cancer detection rate was significantly higher using the SmartBx for patients with PSA<10 (10.1% vs. 7.96%; n=2080 & n=2073, respectively; P<.016). Other subgroups showed non-significant higher detection rate for SmartBx cores. We noticed higher detection rate of clinically significant prostate cancer. Within core cancer length in 160 SmartBx cores was significantly lower compared to standard positive whole cores (4.45mm vs. 10.9mm; P<.001). Assuming cancer site a perfect sphere, disease volume was 11-fold lower for within core compared to entire core (46.1mm vs. 679.9mm; P<.0001). CONCLUSIONS: SmartBx results in significant higher core length, yield and cancer detection rate. Precise localization of within core tumor foci allows significant reduction in tumor volume.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Lavi A, Yudkevich B, Pechansky S, et al. Implications of a Novel Biopsy Downloading System on Prostate Cancer Detection Rate, Surveillance and Focal Therapy - A Prospective Study. Urology. 2021. PMID: 34780845. doi:10.1016/j.urology.2021.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。